Sorry, you need to enable JavaScript to visit this website.

Hereditary Cancer Testing

Hereditary Cancer Testing

The mapping of the human genome has provided medical professionals with the ability to refine a patient’s cancer risk through an analysis of inherited mutations. Approximately 5 to 10 percent of cancers are thought to be caused by mutations in genes that are associated with hereditary cancer syndromes.1

Expand your patients’ understanding of their hereditary cancer risk

When it comes to screening for hereditary cancer syndromes, being able to provide more pertinent information to your patients about their cancer risk is important to their understanding and ability to make informed decisions regarding their healthcare.

Choosing tests based on your patients’ personal and family medical histories can help contribute to that understanding.

Patients, who have personal and family medical histories that include a broad spectrum of cancers, may gain a better understanding, in terms of a risk assessment, by utilizing a multi-gene test like the VistaSeq Hereditary Cancer Panel.

Patients with a family history that is specific to one cancer type may receive more benefit from a focused genetic test such as BRCAssure BRCA 1/2 Analysis or testing for Lynch syndrome.

Because Knowledge is a Powerful Tool.

With the knowledge of your patient’s hereditary cancer mutation status you have the power to tailor prevention and treatment strategies to that patient as well as assist family members in understanding their risk.

Click below for detailed information on our Hereditary Cancer Tests

BRCAssure BRCA 1/2Analysis

Lynch Syndrome

VistaSeq Hereditary Cancer Panel

Reference:

1. Genetic Testing for Hereditary Cancer Syndromes. Available at the website of the National Cancer Institute (http://www.cancer.gov). Accessed May 15, 2015.